Table 1.

Clinical differences among benign, malignant, and dedifferentiated solitary fibrous tumor (SFT)

5YSR, 5-year survival rate.

^aData extracted from Demicco et al.7; ^bData extracted from Collini et al.2; ^c93% for moderate-risk group, 60% for high-risk group.